Publicacións nas que colabora con J.I. Arias Pérez (43)

2016

  1. Breastfeeding and immunohistochemical expression of ki-67, p53 and BCL2 in infiltrating lobular breast carcinoma

    PLoS ONE, Vol. 11, Núm. 3

2015

  1. Histological grade (HG) in invasive ductal carcinomas of the breast of less than 1 cm: Clinical and biological associations during progression from HG1 to HG3

    Anticancer Research, Vol. 35, Núm. 1, pp. 569-574

2014

  1. Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program

    Anticancer Research, Vol. 34, Núm. 1, pp. 269-273

  2. CA15.3 serum concentrations in older women with infiltrating ductal carcinomas of the breast

    International Journal of Molecular Sciences, Vol. 15, Núm. 11, pp. 19870-19876

  3. Positive immunohistochemical expression of bcl-2 in hormone-independent breast carcinomas is associated with a greater lymph node involvement and poor outcome

    Medical Oncology, Vol. 31, Núm. 8

2012

  1. Breast carcinomas with hyperprolactinemia at the time of diagnosis-clinico-biological association

    Gynecological Endocrinology, Vol. 28, Núm. 4, pp. 278-281

  2. CA 15-3 serum levels in patients with ductal breast carcinoma: Relationship with clinicopathological parameters and tumor markers

    International Journal of Biological Markers, Vol. 27, Núm. 1, pp. 47-52

  3. Infiltrating breast carninomas multifocality: Clinical and biological features

    Open Breast Cancer Journal, Vol. 4, pp. 18-23

  4. Only in patients with hormone dependent breast infiltrating ductal carcinomas, CA15.3 serum levels are inversely correlated with the immunohistochemical expression of Bcl2

    Clinica Chimica Acta, Vol. 413, Núm. 21-23, pp. 1792-1795

2008

  1. Reduced clinicopathological influence of hormone-dependence on breast carcinomas in women older than 70 years

    International Journal of Biological Markers, Vol. 23, Núm. 1, pp. 58-62

2007

  1. CA15.3 sérico y proliferación celular en carcinomas ductales infiltrantes de mama

    Revista Espanola de Medicina Nuclear, Vol. 26, Núm. 6, pp. 367-371

2006

  1. Concentraciones séricas preoperatorias de antígeno carbohidrato 15.3 y antígeno carcinoembrionario y características clínico-biológicas tisulares de los carcinomas mamarios

    Revista Espanola de Medicina Nuclear, Vol. 25, Núm. 3, pp. 180-183

  2. Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: A Spanish case-control study

    International Journal of Cancer, Vol. 119, Núm. 2, pp. 467-471

  3. La expresión del receptor del factor de crecimiento epidérmico (EGFR) en carcinomas mamarios hormonoindependientes

    Revista Espanola de Medicina Nuclear, Vol. 25, Núm. 1, pp. 15-19

2005

  1. CD44v6 expression in er-negative and PgR-negative infiltrating ductal breast carcinomas [2]

    Medicina Clinica, Vol. 125, Núm. 12, pp. 475-476

  2. pS2 citosólica y proliferación celular en carcinomas ductales infiltrantes de mama hormonodependientes

    Revista Espanola de Medicina Nuclear, Vol. 24, Núm. 3, pp. 185-190

2004

  1. Invasión de los ganglios axilares en el carcinoma mamario con receptores hormonales negativos

    Medicina Clinica, Vol. 123, Núm. 2, pp. 50-52

  2. La expresión de CD44v6, en carcinomas mamarios RE+ y RP+. Resultados preliminares

    Oncologia

  3. The variant E233G of the rad51d gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutations

    International Journal of Cancer, Vol. 110, Núm. 6, pp. 845-849

2003

  1. Aspectos biológicos peculiares de los carcinomas mucinosos de mama

    Revista Espanola de Medicina Nuclear